Legislation & Regulation
John Carroll
In addition to the 85 percent rule, the department is applying a ‘reasonableness’ criterion. But it’s all bark, no bite.
Medication Management
Thomas Reinke
In an effort to make the best use of specialty drugs, everybody gets into the act at Independence Blue Cross
Plan Watch
Frank Diamond
BlueCross BlueShield of North Carolina’s vigorous patient-centered medical home may be an example to other plans and providers
Tomorrow's Medicine
Thomas Morrow, MD
NuView Life Sciences fuses molecular biology with imaging technology using the radioactive nuclide Copper 64

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report